Treatment Guidelines from The Medical Letter
FROM
ISSUE
136
Drugs for Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

A nonopioid analgesic may be effective for treatment of mild-to-moderate migraine. A triptan is the drug of choice for treatment of moderate-to-severe migraine. The short-acting oral triptans sumatriptan, almotriptan, eletriptan, rizatriptan, and zolmitriptan are similar in their efficacy and speed of onset; naratriptan and frovatriptan have a slower onset and longer duration of action. The nasal spray formulations of sumatriptan and zolmitriptan have a faster onset of action than oral triptans. Subcutaneous sumatriptan is the fastest-acting and most effective triptan formulation. Patients who do not respond to one triptan may respond to another. For prevention of migraine, topiramate, valproate, propranolol, timolol, or metoprolol is recommended.

TREATMENT OF MIGRAINE

Treatment of migraine in the emergency department, which may involve use of intravenous drugs, is not discussed here.

ANALGESICS ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Migraine
Article code: 136a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian